DiaMedica Therapeutics Inc. - Common Stock (NQ:DMAC)
All News about DiaMedica Therapeutics Inc. - Common Stock
DiaMedica Therapeutics Provides Update on ReMEDy2 Trial
October 26, 2022
Via Business Wire
Via Benzinga